CYTOKINETICS, INCORPORATED Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CYTOKINETICS, INCORPORATED stock issued during period, value, new issues for the quarter ending 2024-03-31 was $93.64M.
- CYTOKINETICS, INCORPORATED stock issued during period, value, new issues for the quarter ending 2023-09-30 was $1.31M.
- CYTOKINETICS, INCORPORATED stock issued during period, value, new issues for the quarter ending 2019-09-30 was $11.40M.
- CYTOKINETICS, INCORPORATED stock issued during period, value, new issues for the quarter ending 2019-06-30 was $19.70M.
- CYTOKINETICS, INCORPORATED stock issued during period, value, new issues for fiscal 2023 was $164.23M.
- CYTOKINETICS, INCORPORATED stock issued during period, value, new issues for fiscal 2021 was $296.90M, a 57.19% increase from fiscal 2020.
- CYTOKINETICS, INCORPORATED stock issued during period, value, new issues for fiscal 2020 was $188.88M, a 421.57% increase from fiscal 2019.
- CYTOKINETICS, INCORPORATED stock issued during period, value, new issues for fiscal 2019 was $36.21M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-03-31 | $93.64M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $164.23M 10-K · filed 2024-02-28 | |
| 2023-09-30 | $1.31M 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $296.90M 10-K · filed 2024-02-28 | |
| 2020-12-31 | $188.88M 10-K · filed 2023-03-01 | |
| 2019-12-31 | $36.21M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $11.40M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $19.70M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $5.12M 10-Q · filed 2020-11-06 | |
| 2009-12-31 | $14.52M 10-K · filed 2013-03-15 | |
| 2006-12-31 | $66.92M 10-K · filed 2013-03-15 | |
| 2004-12-31 | $94.00M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |